These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 20934395)

  • 1. Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology.
    Karagiannis GS; Pavlou MP; Diamandis EP
    Mol Oncol; 2010 Dec; 4(6):496-510. PubMed ID: 20934395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the macromolecules for secretory pathway in cancer disease.
    Selvaraj C; Panwar U; Ramalingam KR; Vijayakumar R; Singh SK
    Adv Protein Chem Struct Biol; 2023; 133():55-83. PubMed ID: 36707206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic approaches to decipher cancer cell secretome.
    Brandi J; Manfredi M; Speziali G; Gosetti F; Marengo E; Cecconi D
    Semin Cell Dev Biol; 2018 Jun; 78():93-101. PubMed ID: 28684183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gaining insights into cancer biology through exploration of the cancer secretome using proteomic and bioinformatic tools.
    Papaleo E; Gromova I; Gromov P
    Expert Rev Proteomics; 2017 Nov; 14(11):1021-1035. PubMed ID: 28967788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncoproteomics: Trials and tribulations.
    Zhou L; Li Q; Wang J; Huang C; Nice EC
    Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The secretome signature of malignant mesothelioma cell lines.
    Manfredi M; Martinotti S; Gosetti F; Ranzato E; Marengo E
    J Proteomics; 2016 Aug; 145():3-10. PubMed ID: 26921831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies in functional proteomics: Unveiling the pathways to precision oncology.
    Favicchio R; Thepaut C; Zhang H; Arends R; Stebbing J; Giamas G
    Cancer Lett; 2016 Nov; 382(1):86-94. PubMed ID: 26850375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCSD: the human cancer secretome database.
    Feizi A; Banaei-Esfahani A; Nielsen J
    Database (Oxford); 2015; 2015():bav051. PubMed ID: 26078477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applications.
    Jimenez CR; Verheul HM
    Am Soc Clin Oncol Educ Book; 2014; ():e504-10. PubMed ID: 24857147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers.
    Karagiannis GS; Pavlou MP; Saraon P; Musrap N; Xie A; Batruch I; Prassas I; Dimitromanolakis A; Petraki C; Diamandis EP
    J Proteomics; 2014 May; 103():121-36. PubMed ID: 24681409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncoproteomics: current trends and future perspectives.
    Cho WC; Cheng CH
    Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic strategies and challenges in tumor metastasis research.
    Hudler P; Gorsic M; Komel R
    Clin Exp Metastasis; 2010 Aug; 27(6):441-51. PubMed ID: 20607365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue and plasma proteomics for early stage cancer detection.
    Peng L; Cantor DI; Huang C; Wang K; Baker MS; Nice EC
    Mol Omics; 2018 Dec; 14(6):405-423. PubMed ID: 30251724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plant secretome: unlocking secrets of the secreted proteins.
    Agrawal GK; Jwa NS; Lebrun MH; Job D; Rakwal R
    Proteomics; 2010 Feb; 10(4):799-827. PubMed ID: 19953550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretome proteomics for discovery of cancer biomarkers.
    Makridakis M; Vlahou A
    J Proteomics; 2010 Nov; 73(12):2291-305. PubMed ID: 20637910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics of cancer of hormone-dependent tissues.
    Tyson DR; Ornstein DK
    Adv Exp Med Biol; 2008; 630():133-47. PubMed ID: 18637489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in clinical oncoproteomics.
    Jain KK
    J BUON; 2007 Sep; 12 Suppl 1():S31-8. PubMed ID: 17935275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the proteomic investigation of the cell secretome.
    Brown KJ; Formolo CA; Seol H; Marathi RL; Duguez S; An E; Pillai D; Nazarian J; Rood BR; Hathout Y
    Expert Rev Proteomics; 2012 Jun; 9(3):337-45. PubMed ID: 22809211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of oncoproteomics to cancer biomarker discovery.
    Cho WC
    Mol Cancer; 2007 Apr; 6():25. PubMed ID: 17407558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-depth proteomic profiling of the uveal melanoma secretome.
    Angi M; Kalirai H; Prendergast S; Simpson D; Hammond DE; Madigan MC; Beynon RJ; Coupland SE
    Oncotarget; 2016 Aug; 7(31):49623-49635. PubMed ID: 27391064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.